Page 4098 Federal Register Vol. 66, No. 11 / Wednesday, January 17, 2001 / Rules and Regulations (i) Unsupervised or “take-home” use. To limit the potential for diversion of opioid agonist treatment medications to the illicit market, opioid agonist treatment medications dispensed to patients for unsupervised use shall be subject to the…
NAMA Advocate The Ombudsman NAMA Talk Vol.6 No.2 pdf format Special Focus: Treatment Access In Tough Economic Times. (Fall 2010) Vol.6 No.1 pdf format A New Name for a Revitalized Patient Advocacy Organization. (Winter 2010) Vol.5 No.1 pdf format AATOD Edition, Methadone Under Attack (Spring 2006) Vol.4 No.2 pdf format Accreditation…
LATEST REPORTS Monday, April 16, 2001 April 2000, Governor Dean Promises To Veto Any Methadone Bill (but finally gives in if he is allowed to rewrite the recommendations of his own experts). Act 123 An Act Relating To Treatment Of Opiate Addiction (this links you to Vermont’s website and full text of the…
MARS services include: training in medication assisted recovery, a mix of culturally appropriate support groups, drug and alcohol free social activities, recovery celebratory events, peer leader training and mentoring, and a peer council to help direct the development of the project. The most important part of MARS is the Core Training in Addiction and how…
You can mail in your membership or use PayPal and join on line. Mail Download Membership Application You can download a Membership Application in pdf format. You will need the Adobe Reader to open it and print it. Download Adobe Reader here: Or you can print out a copy from our webpage. Print out a copy…
FOR IMMEDIATE RELEASE: October 9, 2002 NIDA Contact: Michelle Person 301-443-6245 SAMHSA Contact: Leah Young 301-443-8956 NIDA Research and SAMHSA Physician Training Combine to Put Care for Opiate Dependence in Hands of Family Doctor. Buprenorphine, a new medication developed through more than a decade of research supported by the National Institute on Drug Abuse (NIDA),…